Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

BACKGROUND: In 2009 the declaration by the World Health Organization of a global pandemic of influenza-H1N1 virus led to a vaccination campaign to ensure protection for immunocompromised patients. The goal of this study was to determine the efficacy of the 2009 H1N1 vaccine in patients with hematolo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: de Lavallade, Hugues, Garland, Paula, Sekine, Takuya, Hoschler, Katja, Marin, David, Stringaris, Kate, Loucaides, Eva, Howe, Katherine, Szydlo, Richard, Kanfer, Ed, Macdonald, Donald, Kelleher, Peter, Cooper, Nichola, Khoder, Ahmad, Gabriel, Ian H., Milojkovic, Dragana, Pavlu, Jiri, Goldman, John M., Apperley, Jane F., Rezvani, Katayoun
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2011
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031700/
https://ncbi.nlm.nih.gov/pubmed/20971824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.032664
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires